Company intelligence / Profile preview

Reef Technologies

Sydney, New South Wales, Australiareef.pl ↗

Ownership: Private
Development stage: Other

Overview

Reef Health provides pharmaceutical research and manufacturing services with expertise in small molecules/APIs and biologics. The company specializes in custom solutions including sterile manufacturing and vaccine development support. It has experience supporting both traditional infectious agent-based vaccines ("Generation 1") as well as newer recombinant protein/VLP/nucleic acid/vector-based vaccines ("Generation 2 & 3"), including bioanalytical assay development under GMP conditions. No proprietary clinical results are reported.

Therapeutic areas: Infectious Diseases
Modalities: Small moleculeLarge molecule (biologics)VaccineMonoclonal antibody
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Reef Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reef Technologies.

Explore the full profile